Evolent Health (EVH) EBIAT (2016 - 2025)
Historic EBIAT for Evolent Health (EVH) over the last 12 years, with Q3 2025 value amounting to -$20.9 million.
- Evolent Health's EBIAT rose 982.41% to -$20.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$128.2 million, marking a year-over-year decrease of 7745.74%. This contributed to the annual value of -$61.6 million for FY2024, which is 4548.57% up from last year.
- As of Q3 2025, Evolent Health's EBIAT stood at -$20.9 million, which was up 982.41% from -$19.9 million recorded in Q2 2025.
- Over the past 5 years, Evolent Health's EBIAT peaked at $3.1 million during Q4 2021, and registered a low of -$64.6 million during Q1 2025.
- For the 5-year period, Evolent Health's EBIAT averaged around -$17.3 million, with its median value being -$17.3 million (2024).
- As far as peak fluctuations go, Evolent Health's EBIAT skyrocketed by 12870.17% in 2021, and later crashed by 134667.92% in 2025.
- Evolent Health's EBIAT (Quarter) stood at $3.1 million in 2021, then tumbled by 471.73% to -$11.3 million in 2022, then plummeted by 194.4% to -$33.4 million in 2023, then skyrocketed by 31.75% to -$22.8 million in 2024, then increased by 8.5% to -$20.9 million in 2025.
- Its last three reported values are -$20.9 million in Q3 2025, -$19.9 million for Q2 2025, and -$64.6 million during Q1 2025.